First Command Bank’s Takeda Pharmaceutical TAK Stock Holding History

First Command Bank’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-20	Closed	-$1K	–	456
2022 Q2	$1K	Buy	+20	New	+$285	﹤0.01%	431
2020 Q1	–	Sell	-594	Closed	-$12K	–	376
2019 Q4	$12K	Hold	594	–	–	0.01%	300
2019 Q3	$10K	Hold	594	–	–	0.01%	312
2019 Q2	$11K	Buy	+594	New	+$10.8K	0.01%	329

Other funds holding TAK

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

First Command Bank's TAK Position: Q3 2022 in Review

First Command Bank sold out of Takeda Pharmaceutical (TAK) in Q3 2022, closing a stake of 20 shares — an estimated $1K sold.

First Command Bank first reported a position in TAK in Q2 2019 and held it in 4 quarters. The position peaked at $12K in Q4 2019. 276 funds tracked by Wall St. Rank hold TAK as of Q3 2022.

First Command Bank reported no remaining Takeda Pharmaceutical position as of Q3 2022 after selling out during the quarter.
First Command Bank sold 20 Takeda Pharmaceutical shares in Q3 2022, an estimated $1K.
First Command Bank first reported a position in Takeda Pharmaceutical in Q2 2019 and held it in 4 quarters.
First Command Bank's Takeda Pharmaceutical position peaked at $12K in Q4 2019.
276 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2022.

Based on First Command Bank's 13F filing for Q3 2022, filed 24 Oct 2022.